Cynata Therapeutics talks stem cell research at Proactive’s CEO Sessions – Proactive Investors Australia


Find out more from Dr Ross Macdonald at Proactive's CEO Sessions.

Cynata Therapeutics (ASX:CYP) is a stem cell and regenerative medicine company that is developing a therapeutic stem cell platform technology, Cymerus.

The technology addresses a critical shortcoming in existing methods of production of mesenchymal stem cells (MSCs) for therapeutic use.

Cynata is now in a transition to a clinical stage company.

Earlier this year Cynata announced a breakthrough strategic partnership agreement with Fujifilm which included the Japanese company investing in Cynata to become the largest shareholder in the company.

Find out more from Dr Ross Macdonald at Proactive's CEO Sessions.

Click on city below to register by email

- Sydney: Tuesday 14th March. - Melbourne: Wednesday 15th March. - Email Pauline here. - Call office on (02) 9280 0700.

Presenter list

- Legend Mining (ASX:LEG): Mark Wilson. - Cynata Therapeutics (ASX:CYP): Dr Ross Macdonald. - White Cliff Minerals (ASX:WCN): Todd Hibberd. - Bluechiip (ASX:BCT): Andrew McLellan.

Register here to be notified of future CYP Company articles

See original here:
Cynata Therapeutics talks stem cell research at Proactive's CEO Sessions - Proactive Investors Australia

Related Posts